- Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease
[作者：Dean, RM; Fry, T; Mackall, C; Steinberg, SM; Hakim, F; Fowler, D; Odom, J; Foley, J; Gress, R; Bishop, MR,期刊：Journal of clinical oncology, 页码：5735-5741 , 文章类型： Article，,卷期：2008年26-35]
- PurposeMorbidity from acute graft-versus-host disease (GVHD) limits the success of allogeneic hematopoietic stem-cell transplantation (HSCT) to treat malignancy. Interleukin-7 (IL-7), the principal homeostatic cytokine f...
- Impact of Molecular Staging Methods in Primary Melanoma: Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) of Ultrasound-Guided Aspirate of the Sentinel Node Does Not Improve Diagnostic Accuracy, But RT-PCR of Peripheral Blood Does Predict Survival
[作者：Voit, CA; Schafer-Hesterberg, G; Kron, M; van Akkooi, ACJ; Rademaker, J; Lukowsky, A; Schoengen, A; Schwuerzer-Voit, M; Sterry, W; Krause, M; Rowert-Huber, J; Eggermont, AMM,期刊：Journal of clinical oncology, 页码：5742-5747 , 文章类型： Article，,卷期：2008年26-35]
- PurposeThis study analyzes (1) the value of tyrosinase reverse-transcriptase polymerase chain reaction (RT-PCR) of aspirates obtained by ultrasound-guided fine-needle aspiration cytology (US-FNAC) of sentinel nodes (SNs)...
- Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group
[作者：Atkins, MB; Hsu, J; Lee, S; Cohen, GI; Flaherty, LE; Sosman, JA; Sondak, VK; Kirkwood, JM,期刊：Journal of clinical oncology, 页码：5748-5754 , 文章类型： Article，,卷期：2008年26-35]
- PurposePhase II trials with biochemotherapy (BCT) have shown encouraging response rates in metastatic melanoma, and meta-analyses and one phase III trial have suggested a survival benefit. In an effort to determine the r...
- Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer: The Hoosier Oncology Group and US Oncology
[作者：Hanna, N; Neubauer, M; Yiannoutsos, C; McGarry, R; Arseneau, J; Ansari, R; Reynolds, C; Govindan, R; Melnyk, A; Fisher, W; Richards, D; Bruetman, D; Anderson, T; Chowhan, N; Nattam, S; Mantravadi, P; Johnson, C; Breen, T; White, A; Einhorn, L,期刊：Journal of clinical oncology, 页码：5755-5760 , 文章类型： Article，,卷期：2008年26-35]
- PurposeConcurrent chemoradiotherapy is standard treatment for patients with inoperable stage III non-small-cell lung cancer (NSCLC). A phase II study by the Southwest Oncology Group using consolidation docetaxel after ci...
- Phase II Study of Carboplatin and Pemetrexed for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
[作者：Matulonis, UA; Horowitz, NS; Campos, SM; Lee, H; Lee, J; Krasner, CN; Berlin, S; Roche, MR; Duska, LR; Pereira, L; Kendall, D; Penson, RT,期刊：Journal of clinical oncology, 页码：5761-5766 , 文章类型： Article，,卷期：2008年26-35]
- PurposeMore efficacious, less toxic combinations are needed to treat platinum-sensitive recurrent epithelial ovarian cancer (EOC). Pemetrexed is a multitargeted antifolate with manageable toxicity and has been combined w...
- Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning
[作者：Armand, P; Gannamaneni, S; Kim, HT; Cutler, CS; Ho, VT; Koreth, J; Alyea, EP; LaCasce, AS; Jacobsen, ED; Fisher, DC; Brown, JR; Canellos, GP; Freedman, AS; Soiffer, RJ; Antin, JH,期刊：Journal of clinical oncology, 页码：5767-5774 , 文章类型： Article，,卷期：2008年26-35]
- PurposeInhibitors of the mammalian target of rapamycin (mTOR) kinase have shown clinical activity in several lymphoma subtypes. Sirolimus, an mTOR inhibitor, also has activity in the treatment and prophylaxis of graft-ve...
- Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
[作者：Lahuerta, JJ; Mateos, MV; Martinez-Lopez, J; Rosinol, L; Sureda, A; de la Rubia, J; Garcia-Larana, J; Martinez-Martinez, R; Hernandez-Garcia, MT; Carrera, D; Besalduch, J; de Arriba, F; Ribera, JM; Escoda, L; Hernandez-Ruiz, B; Garcia-Frade, J; Rivas-Gonzalez, C; Alegre, A; Blade, J; San Miguel, JF,期刊：Journal of clinical oncology, 页码：5775-5782 , 文章类型： Article，,卷期：2008年26-35]
- PurposeComplete response (CR) is considered an important goal in most hematologic malignancies. However, in multiple myeloma (MM), there is no consensus regarding whether immunofixation (IF)-negative CR, IF-positive near...
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
[作者：Hampel, H; Frankel, WL; Martin, E; Arnold, M; Khanduja, K; Kuebler, P; Clendenning, M; Sotamaa, K; Prior, T; Westman, JA; Panescu, J; Fix, D; Lockman, J; LaJeunesse, J; Comeras, I; de la Chapelle, A,期刊：Journal of clinical oncology, 页码：5783-5788 , 文章类型： Article，,卷期：2008年26-35]
- PurposeIdentifying individuals with Lynch syndrome (LS) is highly beneficial. However, it is unclear whether microsatellite instability (MSI) or immunohistochemistry (IHC) should be used as the screening test and whether...
|